Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...
CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite receiving their ...
The HIV-prevention pill PrEP will now be covered under most insurance plans. Its name is short for pre-exposure prophylaxis. Supporters of the move to make it free to those who are insured call it a ...
Robin O’Donoghue grew up in Fairbanks and first heard about pre-exposure prophylaxis, or PrEP, for preventing HIV transmission when he was in college. PrEP is a daily pill or injection that ...
A little specificity would go a long way in the recommendations of the US Preventive Services Task Force (USPSTF)—that is, if we want health insurance companies to pay for lifesaving HIV prevention ...
Clinical Trials Arena on MSN
JPM26: HIV pipeline dosing optionality gives Gilead advantage
Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
The Kenya Times on MSN
Kenya to introduce long-acting HIV prevention drug in landmark move
Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...
In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the lowest numbers of new HIV diagnoses in decades. New HIV infections were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results